EDVABEY Trademark

Trademark Overview


On Wednesday, February 16, 2022, a trademark application was filed for EDVABEY with the United States Patent and Trademark Office. The USPTO has given the EDVABEY trademark a serial number of 97269161. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, December 21, 2023. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The EDVABEY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations
edvabey

General Information


Serial Number97269161
Word MarkEDVABEY
Filing DateWednesday, February 16, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, December 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Saturday, December 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 21, 2023SOU EXTENSION 2 GRANTED
Thursday, December 21, 2023SOU EXTENSION 2 FILED
Thursday, December 21, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 29, 2023SOU EXTENSION 1 GRANTED
Tuesday, June 27, 2023SOU EXTENSION 1 FILED
Tuesday, August 29, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 2, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, August 2, 2023NOTICE OF REVIVAL - MAILED
Tuesday, August 1, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, August 1, 2023PETITION TO REVIVE-GRANTED
Tuesday, August 1, 2023TEAS PETITION TO REVIVE RECEIVED
Wednesday, August 2, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, August 2, 2023PETITION TO REVIVE-GRANTED
Wednesday, August 2, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, July 31, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 31, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 20, 2022ASSIGNED TO EXAMINER
Tuesday, February 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 19, 2022NEW APPLICATION ENTERED